Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Continuous Monitoring of Upper Limb Function in Neurological Disorders Using a Wearable Sensor
General Neurology
S43 - General Neurology 2 (2:00 PM-2:12 PM)
006

Goal-directed movements (GDMs) play a pivotal role in upper limb motor control, representing planned motor commands directing hand trajectories toward specific targets. Objective monitoring of GDMs during everyday life data offers advantages over traditional methods for assessing upper limb function, providing insights into the quality and complexity of movements. We developed a wearable-based solution that automatically identifies GDMs and extracts GDM characteristics that capture sensitive biomarkers of upper limb health in neurological disorders. 

To assess upper limb function in neurological disorders through continuous monitoring of hand goal-directed movements during activities of daily living using a wrist-worn wearable sensor.

Participants diagnosed with amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), and Friedreich's ataxia (FA) wore a PAMSys ULM™ (BioSensics LLC, Newton, MA USA) wrist sensor for one week after a clinical visit. The deep-learning model detected GDMs, extracting pertinent features characterizing movement quality. Disease-specific clinical assessments (e.g., mFARS, UHDRS, ALSFRS-R) were conducted, and Spearman correlations were performed to examine associations between clinical scores and GDM features.

The study comprised 40 FA participants (average age: 26.7 ± 1.5 years, including 19 females), 25 HD and prodromal HD participants (average age: 41.7 ± 11.2 years, 15 females), and 11 ALS patients (8 males, 3 females; age: 64.4 ± 9.8 years). Strong to moderate correlations were observed between disease-related clinical scores and GDM features, including average daily GDM counts (p=0.008, ρ = 0.576) and entropy of movement elements (p=0.047, ρ = 0.423). In addition, machine learning-based models were developed to predict upper limb health in each of the three disease areas.

Our study presents a wearable-based remote monitoring solution to assess upper limb health by detecting and characterizing GDMs through continuous wrist movement monitoring.

Authors/Disclosures
Adonay Nunes (Biosensics)
PRESENTER
No disclosure on file
Ram Kinker Mishra (Biosensics) No disclosure on file
Jose Casado (BioSensics LLC) No disclosure on file
Nima Dana No disclosure on file
Andrew Geronimo No disclosure on file
Zachary Simmons, MD, FAAN (Penn State Hershey Med Center) Dr. Simmons has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cytokinetics. The institution of Dr. Simmons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amylyx. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Simmons has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Simmons has received research support from MGH. The institution of Dr. Simmons has received research support from MT Pharma. The institution of Dr. Simmons has received research support from University of Kansas. The institution of Dr. Simmons has received research support from ALS Association. The institution of Dr. Simmons has received research support from Clene.
David R. Lynch, MD, PhD (Children's Hospital of Philadelphia) The institution of Dr. Lynch has received research support from reata. The institution of Dr. Lynch has received research support from PTC. Dr. Lynch has received intellectual property interests from a discovery or technology relating to health care.
Ashkan Vaziri, PhD (Biosensics LLC) Dr. Vaziri has received personal compensation for serving as an employee of Biosensics.